Learn from the Nobel Prize Committee: Remove the nominee from the process.

IF 2.2 4区工程技术 Q3 PHARMACOLOGY & PHARMACY Bioimpacts Pub Date : 2021-01-01 Epub Date: 2021-07-30 DOI:10.34172/bi.2021.38

Morteza Mahmoudi, Pooya Sareh

引用次数: 0

Abstract

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

向诺贝尔奖委员会学习:将被提名人从评选过程中剔除。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Bioimpacts Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science

CiteScore

4.80

自引率

7.70%

发文量

审稿时长

5 weeks

期刊介绍： BioImpacts (BI) is a peer-reviewed multidisciplinary international journal, covering original research articles, reviews, commentaries, hypotheses, methodologies, and visions/reflections dealing with all aspects of biological and biomedical researches at molecular, cellular, functional and translational dimensions.

期刊最新文献

A novel imidazo[1,2-a]pyridine derivative and its co-administration with curcumin exert anti-inflammatory effects by modulating the STAT3/NF-κB/iNOS/COX-2 signaling pathway in breast and ovarian cancer cell lines. Regulation of cell fate by cell imprinting approach in vitro. Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies. Design and implementation of a lab-on-a-chip for assisted reproductive technologies. Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL).